Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05083130
What this trial is testing

Awake Prone Positioning in Moderate to Severe COVID-19

Who this might be right for
COVID-19SARS-CoV2 InfectionCOVID-19 Acute Respiratory Distress Syndrome+2 more
Oxford University Clinical Research Unit, Vietnam 93
Large-scale testing (Phase 3)Study completedNCT04600895
What this trial is testing

The Prevent Severe COVID-19 (PRESECO) Study

Who this might be right for
Covid19
Appili Therapeutics Inc. 1,187
Post-approval studies (Phase 4)UnknownNCT04359615
What this trial is testing

Favipiravir in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Testing effectiveness (Phase 2)UnknownNCT04969172
What this trial is testing

A Phase II Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Exosomes Overexpressing CD24 to Prevent Clinical Deterioration in Patients With Moderate or Severe COVID-19 Infection

Who this might be right for
COVID-19 Disease
Eli Sprecher, MD 155
Testing effectiveness (Phase 2)Ended earlyNCT04363437
What this trial is testing

COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19

Who this might be right for
Coronavirus Infection
Maimonides Medical Center 21
Testing effectiveness (Phase 2)Study completedNCT04533347
What this trial is testing

Tafenoquine in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID 19 Disease
60 Degrees Pharmaceuticals LLC 86
Testing effectiveness (Phase 2)UnknownNCT04338802
What this trial is testing

Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19

Who this might be right for
COVID-19NintedanibSafety+1 more
Huilan Zhang 96
Testing effectiveness (Phase 2)Study completedNCT04561219
What this trial is testing

Nitazoxanide Therapy for Patients With COVID-19 Pneumonia

Who this might be right for
Covid19Corona Virus InfectionPneumonia, Viral
Universidade Federal do Rio de Janeiro 500
Very early researchWithdrawnNCT04323631
What this trial is testing

Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death

Who this might be right for
COVID-19
Rambam Health Care Campus
Testing effectiveness (Phase 2)WithdrawnNCT05085574
What this trial is testing

Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)

Who this might be right for
2019 Novel Coronavirus Disease2019 Novel Coronavirus Infection2019-nCoV Disease+9 more
Leidos Life Sciences
Large-scale testing (Phase 3)Ended earlyNCT04403685
What this trial is testing

Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers

Who this might be right for
COVIDSARS PneumoniaCytokine Release Syndrome
Beneficência Portuguesa de São Paulo 129
Large-scale testing (Phase 3)Ended earlyNCT04529499
What this trial is testing

Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients

Who this might be right for
Covid19
Dr. Reddy's Laboratories Limited 353
Post-approval studies (Phase 4)UnknownNCT05697055
What this trial is testing

Efficacy and Safety of Azvudine vs. Nirmatrelvir-Ritonavir in the Treatment of COVID-19 Infection

Who this might be right for
COVID-19
Shandong Provincial Hospital 410
Not applicableStudy completedNCT07072793
What this trial is testing

A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe

Who this might be right for
COVID-19 (Coronavirus Disease 2019)
Pfizer 131,005
Large-scale testing (Phase 3)Ended earlyNCT04371393
What this trial is testing

MSCs in COVID-19 ARDS

Who this might be right for
Mesenchymal Stromal CellsRemestemcel-LAcute Respiratory Distress Syndrome+1 more
Icahn School of Medicine at Mount Sinai 223
Large-scale testing (Phase 3)Study completedNCT04603729
What this trial is testing

Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease

Who this might be right for
Covid 19 Disease
Fatima Memorial Hospital 100
Not applicableUnknownNCT06452069
What this trial is testing

Efficacy and Safety Study of Essential Oil-Based Preparation Administered to COVID-19 Patients

Who this might be right for
COVID-19 Respiratory InfectionCOVID-19
Biodex S.A 280
Testing effectiveness (Phase 2)Study completedNCT04453384
What this trial is testing

Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia

Who this might be right for
SARS Virus
Nantes University Hospital 416
Early research (Phase 1)Study completedNCT04766931
What this trial is testing

The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection

Who this might be right for
Covid19
Frontier Biotechnologies Inc. 88
Not applicableStudy completedNCT05343728
What this trial is testing

Thromboelastographic Methods in Deciding Therapy on Moderate to Severe COVID-19 Patients

Who this might be right for
COVID-19
Universitas Indonesia 100
Next Page